What are the recommended medications for treating migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Medications for Migraine Treatment

For most migraine sufferers, nonsteroidal anti-inflammatory drugs (NSAIDs) are the first-line therapy for acute attacks, while triptans should be used when NSAIDs fail or for moderate to severe migraines. 1, 2

Acute Treatment Algorithm

First-Line Therapy (Mild to Moderate Attacks)

  • NSAIDs:
    • Ibuprofen 400-800 mg every 6 hours
    • Naproxen sodium 275-550 mg every 2-6 hours
    • Aspirin 650-1000 mg every 4-6 hours
    • Acetaminophen-aspirin-caffeine combination

Note: Acetaminophen alone is ineffective and should not be used as monotherapy 2, 1

Second-Line Therapy (Moderate to Severe Attacks or NSAID Failure)

  • Triptans:
    • Sumatriptan 50-100 mg orally
    • Rizatriptan 5-10 mg orally
    • Zolmitriptan 2.5-5 mg orally
    • Naratriptan 1-2.5 mg orally

Clinical evidence shows that sumatriptan 100 mg provides better pain-free response than 50 mg, with NNT of 4.7 versus 6.1 for pain-free at two hours 3

Special Considerations for Nausea/Vomiting

  • Use non-oral routes when nausea/vomiting is prominent:
    • Sumatriptan subcutaneous injection 6 mg
    • Intranasal triptans
    • Dihydroergotamine (DHE) nasal spray
  • Add antiemetics to treat nausea even in patients who are not vomiting 2

Contraindications and Precautions

  • Triptans are contraindicated in:

    • Uncontrolled hypertension
    • Coronary artery disease
    • Basilar or hemiplegic migraine
    • Within 24 hours of ergotamine use 1, 4
  • Opioids should be avoided except when other medications cannot be used, risk of abuse has been addressed, and sedation is not a concern 2, 1

Preventive Therapy

Indications for Preventive Therapy

Evaluate for preventive therapy if patient has:

  • Two or more attacks per month with disability lasting ≥3 days/month
  • Failure of or contraindication to acute treatments
  • Use of abortive medication more than twice per week
  • Presence of uncommon migraine conditions (hemiplegic migraine, migraine with prolonged aura) 2

First-Line Preventive Medications

  • Propranolol 80-240 mg/day
  • Timolol 20-30 mg/day
  • Amitriptyline 30-150 mg/day
  • Divalproex sodium 500-1500 mg/day
  • Sodium valproate 800-1500 mg/day 2, 1

Common Pitfalls and How to Avoid Them

  1. Medication Overuse Headache:

    • Limit acute therapy to no more than twice per week
    • Consider preventive therapy if acute medications are needed frequently 2, 1
  2. Delayed Treatment:

    • Triptans are most effective when taken early while pain is still mild 3
    • Using the "stratified-care" approach (assigning treatment based on migraine severity) is superior to the "step-care" approach 1
  3. Inadequate Treatment of Associated Symptoms:

    • Always address nausea, even in patients who are not vomiting
    • Consider non-oral routes when nausea/vomiting is prominent 2, 1
  4. Recurrence:

    • Approximately 40% of patients experience headache recurrence within 24 hours after initial response to triptans
    • A second dose of the same medication is usually effective for recurrence 5, 4
  5. Ignoring Patient Preferences:

    • Patient preference studies show varying preferences for triptan dosing
    • Some patients prefer higher doses (100 mg) for better efficacy despite slightly more side effects 6

By following this evidence-based approach to migraine management, clinicians can significantly reduce patient morbidity and improve quality of life through effective control of both acute attacks and prevention of future episodes.

References

Guideline

Migraine Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Sumatriptan (oral route of administration) for acute migraine attacks in adults.

The Cochrane database of systematic reviews, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.